Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis
Open Access
- 5 January 2025
- journal article
- research article
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 91 (2) , 101555
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitisAllergology International, 2023
- The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in JapanThe Laryngoscope, 2020
- Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatmentAuris Nasus Larynx, 2020
- Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis mediaAuris Nasus Larynx, 2019
- Cochlear implantation in deaf patients with eosinophilic otitis media using subtotal petrosectomy and mastoid obliterationEuropean Archives of Oto-Rhino-Laryngology, 2016
- Risk factors associated with severity of eosinophilic otitis mediaAuris Nasus Larynx, 2014
- Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear diseaseAuris Nasus Larynx, 2011
- Cochlear implantation in patients with chronic otitis mediaAuris Nasus Larynx, 2010
- Eustachian Tube Function in Patients With Eosinophilic Otitis Media Associated With Bronchial Asthma Evaluated by SonotubometryJAMA Otolaryngology–Head & Neck Surgery, 2006
- Cochlear implantation in a patient with eosinophilic otitis mediaEuropean Archives of Oto-Rhino-Laryngology, 2005